Belgium Anticancer Fund

article

Achieving sustainable innovation with value-added medicines

26 August 2021 | By Hannah Balfour (European Pharmaceutical Review)

The COVID-19 pandemic spotlighted drug repurposing as a key strategy to support traditional novel chemical entity development; yet repurposing is just one example of how off-patent molecules can be further developed to provide patients with more treatment options. Here, Arun Narayan, Chairman of the Value Added Medicines Sector Group at…

article

The many advantages of repurposing existing drugs

26 June 2020 | By Dave Elder (David P Elder Consultancy), Stephen Tindal (Catalent Pharma Solutions)

Repurposing existing drugs can be attractive as the process is often less risky, more cost effective and can be undertaken in less time. This article discusses the logic behind drug repurposing and the approaches that are currently being explored.